Company Details
  • Conbott Pharmtech Co.,Ltd.

  •  [Zhejiang,China]
  • Business Type:Manufacturer
  • Main Markets: Africa , Americas , Asia , Caribbean , East Europe , Europe , Middle East , North Europe , Oceania , Other Markets , West Europe , Worldwide
  • Exporter:71% - 80%
  • Certs:COS, ISO9001, ISO14010, FDA
  • Description:Thrombopoietin Receptor Agonist,Thrombopoietin,Thrombopoietin Agonists
Conbott Pharmtech Co.,Ltd. Thrombopoietin Receptor Agonist,Thrombopoietin,Thrombopoietin Agonists
Home > Products > Intermediates > Thrombopoietin Receptor Agonist
  • Title
  • All
Online Service
http://www.conbottpharm.comScan to visit

Thrombopoietin Receptor Agonist

Product categories of Thrombopoietin Receptor Agonist, we are specialized manufacturers from China, Thrombopoietin Receptor Agonist, Thrombopoietin suppliers/factory, wholesale high-quality products of Thrombopoietin Agonists R & D and manufacturing, we have the perfect after-sales service and technical support. Look forward to your cooperation!
View: List Grid
Eltrombopag Olamine Intermediate, CAS 376592-93-7
Eltrombopag Olamine Intermediate, CAS 376592-93-7

Model No. : 376592-93-7

We are professional supplier of intermediate for Eltrombopag Olamine CAS 376592 93 7 which is very useful The Eltrombopag Olamine Intermediate CAS NO 376592 93 7 is high purity because it processed precisely We can offer competitive price and fast...

China Manufacturer of Thrombopoietin Receptor Agonist

China Thrombopoietin Receptor Agonist Suppliers

The main clinical application of Thrombopoietin Receptor Agonist is as therapeutic agents of thrombocytopenia, especially thrombocytopenia caused by chemotherapy and radiotherapy. Thrombopoietin Receptor Agonist in vivo experiments have shown that it not only increase platelet levels more effectively than other hematopoietic factors, but also has the ability to promote the viability of other hematopoietic cell lines. At the same time there are other studies confirm that Thrombopoietin Receptor Agonist not only stimulate growth megakaryocyte progenitor cells in vivo to increase its polyploidy, but also is effective in promoting bone marrow precursor cells Lin-Sca-1 + precursor activity, their offspring not only has the potential to generate megakaryocytes, also can be generated as bone marrow lines. Visiblely, Thrombopoietin Receptor Agonist will greatly reduce the risk of chemotherapy and bone marrow transplantation, effective treatment of thrombocytopenia and possibly other related disorders. Therefore Thrombopoietin Receptor Agonist will have broad application prospects.

Conbottpharm could give you:
1. Best quality in your requirement
2. Competitive price in China market
3. Mature Technical support
4. Professional logistic support
All we want is win-win business. Send yr. inquiries, you will get it!
Copyright © 2021 Conbott Pharmtech Co.,Ltd. All rights reserved.
Communicate with Supplier?Supplier
Tommy Mr. Tommy
What can I do for you?